about
Adrenocortical carcinoma presenting as varicocele and renal vein thrombosis: a case reportA case of non-functioning huge adrenocortical carcinoma extending into inferior vena cava and right atrium.Adrenocortical carcinoma posing as a pheochromocytoma: a diagnostic dilemmaAdrenal incidentaloma: a case of carcinoma.Videoscopic adrenalectomy - when does retroperitoneal seem better?How is adrenocortical cancer being managed in the UK?Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome)Current and emerging therapies for advanced adrenocortical carcinoma.Liver resection and ablation for metastatic adrenocortical carcinomaAdrenocortical tumors and hyperplasias in childhood--etiology, genetics, clinical presentation and therapy.Pathway Implications of Aberrant Global Methylation in Adrenocortical CancerCurrent and emerging therapeutic options in adrenocortical cancer treatment.Adrenohepatic fusion: Adhesion or invasion in primary virilizant giant adrenal carcinoma? Implications for surgical resection. Two case report and review of the literature.Adrenocortical tumorigenesis.Functioning adrenocortical tumors in children-secretory behaviorAdrenal cortical carcinoma with tumor thrombus extension into the right atrium: A case report.Mitotane-induced hyperlipidemia: a retrospective cohort study.Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?Clinical and imaging overview of functional adrenal neoplasms.Adrenocortical carcinoma: past, present, and future.Response to radiation therapy in adrenocortical carcinoma.Retroperitoneal hemorrhage from adrenocortical carcinoma as a poor prognostic factor.Robot-assisted vs open adrenalectomy: evaluation of cost-effectiveness and peri-operative outcome.Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?Multiple retroperitoneal schwannomas mimicking adrenal tumors.Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells.Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results.Pulmonary Embolism as an Initial Presentation of Adrenocortical Carcinoma.Challenges in surgical pathology of adrenocortical tumours.Angiogenesis and Lymphangiogenesis in the Adrenocortical Tumors.Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane.Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma.Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas.Adrenocortical carcinoma
P2860
Q21202086-F87BBAC6-AC4E-4BAF-BA02-B0CA54F7FA3FQ33371585-8A7E8971-5138-4D2F-BAB9-C9BBD6F8D6F7Q33595551-DF62F1F2-DC96-4615-9D80-997BEB546126Q33787124-BB2A45B6-0EB8-4A49-A2E9-11A2F864FEBAQ33928729-4AC0BDD0-41DA-4454-8318-6F242C409E4CQ34251801-48F96107-2FFF-417F-BE63-7EC1218E2712Q35095366-CAFE4E9C-F587-41A3-9291-21553895DF45Q35584305-D9392CCD-787D-4E72-A279-D0E789B82D0AQ35738507-3551C4F6-08E7-48A4-BAC8-7ED7490D4785Q35870396-F81B97BB-4FFF-40EC-A033-5FE2899BBAA9Q35952358-43BD79D3-2145-49CA-9F04-298B4590C559Q36183873-A12DD738-4336-449B-97EB-7C8722DA4FD6Q36431728-5FA05F4F-3881-4419-9110-B5305A74618FQ36694025-40FA8730-7E1C-4131-B1DF-5C2CFD481C93Q36772151-1AAD85DC-9717-48AD-A9B1-7AF4A1E32283Q36954621-19F36D88-6D0A-4A96-BAA7-D26A13FB6FC4Q37358489-C17C3498-A440-493E-8E85-07FCDFBEFF21Q37924953-9199622C-8201-43FC-8AE9-DA85687097BEQ37998534-30365905-D3DB-414A-9B9B-ECFB8305B8D9Q37999696-666C2C81-2EBF-435B-99ED-551BC6713A1FQ39289780-F4845EA6-28FC-4D75-877C-2F738A53524AQ39526039-293F51C4-F6F8-454B-B251-A8992AAC3C83Q39773547-67E4EC20-636D-458E-A19D-AF1CBA0D3636Q40180747-CB82509E-314A-4213-B57F-361D91B41092Q42186154-76EB57DF-A565-4D09-B707-8AF37685C287Q45774997-EB4CC1EB-7288-4A67-B3B4-4C3AC5F90BFCQ46887081-90FC33A6-14AC-425E-AFFE-F159F044CD61Q47140111-9C5298E2-FA8F-4D5C-AD18-9B4C04790587Q47576824-AE893611-9596-4568-B326-C037A5E677C5Q50898198-85CE0991-2831-4F26-A00B-CD2CBFD475D8Q51795765-9E79142B-E05A-47BD-9F28-801BD39EE6A1Q51980531-60B9419D-AE74-4695-9E40-12A2DAE3E5D9Q53187320-346AB105-387E-4605-A9D1-04BED8CC3878Q57645859-BEEEC8BF-31BB-445E-992E-72AC4D7B00C3
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Management of adrenocortical carcinoma.
@ast
Management of adrenocortical carcinoma.
@en
type
label
Management of adrenocortical carcinoma.
@ast
Management of adrenocortical carcinoma.
@en
prefLabel
Management of adrenocortical carcinoma.
@ast
Management of adrenocortical carcinoma.
@en
P2093
P1476
Management of adrenocortical carcinoma.
@en
P2093
Bruno Allolio
Dirk Weismann
Martin Fassnacht
P304
P356
10.1046/J.1365-2265.2003.01881.X
P577
2004-03-01T00:00:00Z